Citigroup and Raymond James Financial published research reports and price targets for a company whose stock trades on the Nasdaq platform.
Steady: 0 in the last 7 days
Updated oct 8
The latest in this situation
How it started
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Citigroup and Raymond James Financial published research reports and price targets for a company whose stock trades on the Nasdaq platform.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Citigroup and Raymond James Financial initiated coverage of Rapport Therapeutics with rating upgrades.1 source
- Citigroup increased its price target on SunocoCorp LLC, while Raymond James Financial reaffirmed its strong-buy rating on the company.Sub-event
- Raymond James Financial raised shares of Walt Disney.Sub-event
- Citigroup provided rating and price targets for ProQR Therapeutics stock.Sub-event
- Raymond James Financial, Boston Partners, and GQG Partners raised holdings in Allstate, and Citigroup boosted its target price on the company.Sub-event
Research reports published on the stock price of company APA.1 source
Keep exploring
The entities involved
-
Citigroup
American investment bank and financial services corporation
-
Raymond James Financial
American Investment Bank and Financial Services Firm
-
MarketScreener
Online media for stock market investors
Nothing else this week.
Related events
- Citigroup reiterated a market perform rating, Bank of America restated an underperform rating, and Raymond James Financial started coverage for Omega Healthcare Investors, Inc.
- Raymond James Financial provided research reports on Alignment Healthcare, Inc., whose stock trades on Nasdaq, with data reported on MarketBeat.
- Multiple financial firms, including Citigroup and Truist Financial, issued rating changes, price targets, and stake acquisitions related to C. H. Robinson Worldwide.
- Citigroup reduced its price objective for Morgan Stanley stock on October 18, 2026.
- Privia Health Group, Inc. shares are listed on the Nasdaq exchange, and Citigroup reissued a buy rating on the stock.
Coverage
Newest first; wire copies grouped- tickerreport.com
- themarketsdaily.com
- themarketsdaily.com
- dailypolitical.com
- tickerreport.com
- tickerreport.com
- tickerreport.com